|
21. |
The use of hemoglobin as a blood substitute |
|
American Journal of Hematology,
Volume 42,
Issue 1,
1993,
Page 112-117
H. Franklin Bunn,
Preview
|
PDF (567KB)
|
|
ISSN:0361-8609
DOI:10.1002/ajh.2830420122
出版商:Wiley Subscription Services, Inc., A Wiley Company
年代:1993
数据来源: WILEY
|
22. |
Composition of the hemoglobin S polymer |
|
American Journal of Hematology,
Volume 42,
Issue 1,
1993,
Page 118-121
Robert M. Bookchin,
Tania Balazs,
Virgilio L. Lew,
Preview
|
PDF (379KB)
|
|
ISSN:0361-8609
DOI:10.1002/ajh.2830420123
出版商:Wiley Subscription Services, Inc., A Wiley Company
年代:1993
数据来源: WILEY
|
23. |
Evolution of clinical understanding: Paroxysmal nocturnal hemoglobinuria as a paradigm |
|
American Journal of Hematology,
Volume 42,
Issue 1,
1993,
Page 122-126
Wendell F. Rosse,
Preview
|
PDF (456KB)
|
|
ISSN:0361-8609
DOI:10.1002/ajh.2830420124
出版商:Wiley Subscription Services, Inc., A Wiley Company
年代:1993
数据来源: WILEY
|
24. |
Adult and childhood acute lymphocytic leukemia: Are they different diseases? |
|
American Journal of Hematology,
Volume 42,
Issue 1,
1993,
Page 127-131
Alvin M. Mauer,
Preview
|
PDF (436KB)
|
|
摘要:
AbstractAge has long been recognized as an important factor in predicting response to treatment for acute lymphocytic leukemia (ALL). Specifically, the results of treatment of childhood ALL have been far superior to the treatment of what appears to be the same disease in adults. However, from an analysis of the clinical and biological prognostic factors known to be predictive in childhood ALL, there is a striking difference in their distribution in adults with ALL. It appears that there is a special form of ALL seen in children of some populations with a peak incidence of three to seven years. This treatment responsive leukemia appears to be different clinically, biologically, and epidemiologically from adult ALL. © 1993 Wiley‐Liss, I
ISSN:0361-8609
DOI:10.1002/ajh.2830420125
出版商:Wiley Subscription Services, Inc., A Wiley Company
年代:1993
数据来源: WILEY
|
25. |
Agranulocytosis during antibiotic therapy: Drug sensitivity or sepsis? |
|
American Journal of Hematology,
Volume 42,
Issue 1,
1993,
Page 132-137
Anthony V. Pisciotta,
Preview
|
PDF (507KB)
|
|
摘要:
AbstractForty‐three patients reviewed from the literature and five cases of agranulocytosis during antibiotic therapy studied by the author are presented. Time required to develop agranulocytosis with antibiotics was40 days required with nonantibiotic drugs. In all, agranulocytosis occurred concomitantly with drug treatment and became normal as treatment was discontinued. Retrospective rechallenge studies suggest that agranulocytosis may be dose related. In all cases PMNs were almost completely deleted and marrows were devoid of granulocyte precursors. In contrast, leukopenia secondary to overwhelming sepsis displayed persisting granulocytes in peripheral blood and marrow. While leukagglutinins were not found in nine cited cases, four serums were toxic to test PMNs as measured by suppression of postphagocytosis respiratory burst. Clindamycin directly suppressed development of CFU‐G in one sensitive patient but not in 16 normal controls. The hazard of antibiotics in suppressing granulocytopoiesis is emphasized by these observations. © 1993 Wiley‐Lis
ISSN:0361-8609
DOI:10.1002/ajh.2830420126
出版商:Wiley Subscription Services, Inc., A Wiley Company
年代:1993
数据来源: WILEY
|
26. |
Inhibition of the activation of hageman factor (factor XII) by eosinophils and eosinophilic constituents |
|
American Journal of Hematology,
Volume 42,
Issue 1,
1993,
Page 138-145
Oscar D. Ratnoff,
Gerald J. Gleich,
Susan B. Shurin,
James Kazura,
Barbara Everson,
Paula Embury,
Preview
|
PDF (614KB)
|
|
摘要:
AbstractSeveral syndromes characterized by striking eosinophilia may be complicated by thrombosis. The experiments described indicate that, paradoxically, eosinophils and certain of their constituents inhibit the activation of Hageman factor (HF, factor XII). In earlier studies, suspensions of mixed types of granulocytes, other nucleated peripheral blood cells, and platelets inhibited activation of Hageman factor by ellagic acid, glass, and sulfatides. After these cells were sedimented by centrifugation, the supernatant fluids were also inhibitory. No attempt had been made earlier to distinguish among different granulocytic species. In the present study, suspensions of eosinophils and the supernatant fluid after eosinophils had been separated by centrifugation inhibited activation of Hageman factor by ellagic acid. The protein concentration of that amount of supernatant fluid that inhibited activation by about half was 16 μg/ml, approximately the same as had been described for suspensions of peripheral blood mononuclear cells. Activation of Hageman factor by ellagic acid was also inhibited by certain constituents of eosinophils, including eosinophil peroxidase, eosinophil major basic protein and eosinophil cationic protein. Inhibition was not specific for ellagic acid‐induced activation of Hageman factor, as inhibition was also observed with sulfatide‐induced activation. Inhibition was presumably related to neutralization of the negative charge of activators of Hageman factor. Thus, bismuth subgallate, a particulate activator of Hageman factor, was no longer effective after it had been exposed to eosinophil cationic protein. The observations reported here raise the question of whether in vivo eosinophils modulate certain of the defense reactions ascribed to Hageman factor. © 1993 Wiley‐Li
ISSN:0361-8609
DOI:10.1002/ajh.2830420127
出版商:Wiley Subscription Services, Inc., A Wiley Company
年代:1993
数据来源: WILEY
|
27. |
Masthead |
|
American Journal of Hematology,
Volume 42,
Issue 1,
1993,
Page -
Preview
|
PDF (23KB)
|
|
ISSN:0361-8609
DOI:10.1002/ajh.2830420101
出版商:Wiley Subscription Services, Inc., A Wiley Company
年代:1993
数据来源: WILEY
|
|